Problems and methods in health care economics: is personalized medicine an exception?

被引:0
|
作者
Sickinger, Sabine [1 ]
Payne, Katherine [2 ]
Rogowski, Wolf [1 ]
机构
[1] Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Inst Gesundheitsokon & Management Gesundheitswese, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany
[2] Univ Manchester, Inst Populat Hlth, Manchester, Lancs, England
关键词
Personalized medicine; Health economic evaluation; Evidence-based decision making; INDIVIDUALIZED CARE; DECISION-MAKING; EMPOWERMENT; INFORMATION;
D O I
10.1007/s00481-013-0266-4
中图分类号
R-052 [医学伦理学];
学科分类号
0101 ; 120402 ;
摘要
Objective For the economic evaluation of medical services, a well-established range of methods is available. The aim of this paper is to determine how and to what extent these methods are applicable to the much-discussed area of personalized medicine and which features may be encountered and how they can be addressed. Methods For this study, an exploratory literature search was conducted. Results In contrast to conventional medicine, personalized medicine might be considered either in terms of physiological differences or in terms of individual preferences of the participants. Depending on the approach, there are different implications for the methodological challenges in health economic evaluations. Improving health care provision regarding physiological differences brings up the problem of parameterization, since evidence is often very weak due to small sample sizes. Value of information analysis can reveal details about the potential benefits of further research. The concept of "expected value of individualized care" provides a very similar approach to the value of information analysis to quantify the potential value of including individual preferences in the health care provision. Welfarism and Extra Welfarism offer different solutions, such as how benefits of biomarker-based information in the sense of "empowerment" can be included in evaluations. Conclusion In general, the methods of economic evaluation are applicable to the field of personalized medicine. However, a number of specific challenges exist. Further research is necessary to solve these problems.
引用
收藏
页码:267 / 275
页数:9
相关论文
共 50 条
  • [41] Implementing a personalized medicine program in a community health system
    Dressler, Lynn G.
    Bell, Gillian C.
    Ruch, Karl D.
    Retamal, Jennifer D.
    Krug, Paige B.
    Paulus, Ronald A.
    PHARMACOGENOMICS, 2018, 19 (17) : 1345 - 1356
  • [42] Evaluating Translational Methods for Personalized Medicine-A Scoping Review
    Fosse, Vibeke
    Oldoni, Emanuela
    Gerardi, Chiara
    Banzi, Rita
    Fratelli, Maddalena
    Bietrix, Florence
    Ussi, Anton
    Andreu, Antonio L.
    McCormack, Emmet
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (07):
  • [43] Personalized Medicine in Screening for Malignant Disease: A Review of Methods and Applications
    Schmalfuss, F.
    Kolominsky-Rabas, P. L.
    BIOMARKER INSIGHTS, 2013, 8 : 9 - 14
  • [44] Making personalized medicine ethical: a critical examination of the new promises of 'personalized health' in Switzerland
    Barazzetti, Gaia
    Buehler, Nolwenn
    Audetat, Marc
    Kaufmann, Alain
    SCIENCE AND PUBLIC POLICY, 2021, 48 (06) : 818 - 828
  • [45] The economics of mental health and health care - a blind spot?
    Schwappach, David L. B.
    NEUROPSYCHIATRIE, 2007, 21 (01) : 18 - 28
  • [46] Personalized health care: From theory to practice
    Snyderman, Ralph
    BIOTECHNOLOGY JOURNAL, 2012, 7 (08) : 973 - 979
  • [47] Personalized Critical Care Medicine: How Far Away Are We?
    Ahasic, Amy M.
    Christiani, David C.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 36 (06) : 809 - 822
  • [48] The role of informatics in patient-centered care and personalized medicine
    Hanna, Matthew G.
    Pantanowitz, Liron
    CANCER CYTOPATHOLOGY, 2017, 125 : 494 - 501
  • [49] Collaboration as a foundation for advancing research in personalized medicine in cancer care
    Krasna, Mark J.
    PERSONALIZED MEDICINE, 2010, 7 (06) : 669 - 675
  • [50] Primary care providers' experiences with and perceptions of personalized genomic medicine
    Carroll, June C.
    Makuwaza, Tutsirai
    Manca, Donna P.
    Sopcak, Nicolette
    Permaul, Joanne A.
    O'Brien, Mary Ann
    Heisey, Ruth
    Eisenhauer, Elizabeth A.
    Easley, Julie
    Krzyzanowska, Monika K.
    Miedema, Baukje
    Pruthi, Sandhya
    Sawka, Carol
    Schneider, Nancy
    Sussman, Jonathan
    Urquhart, Robin
    Versaevel, Catarina
    Grunfeld, Eva
    CANADIAN FAMILY PHYSICIAN, 2016, 62 (10) : E626 - E635